Generics US-Congressional

Previous Page 1 of 6 Next >

Search returned 59 items.

sort by: Title | Author | Publication | Date

Tomorrow's Drugs

Seven top therapies and technologies vying to deliver the next decade's breakthroughs and blockbusters. They want to become...

Date: 07/30/2007 , Publication: Pharmaceutical Executive , Author: The Staff of Pharmaceutical Executive

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=446938

From the Editor: Post-regulatory

The Acomplia story isn't ending. It's just beginning.

Date: 07/03/2007 , Publication: Pharmaceutical Executive , Author: Patrick Clinton

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=442273

Washington Report: Vaccines for Everyone

New vaccines can be good business and a huge boon to public health. But the challenge is to establish prices that ensure global access.

Date: 07/03/2007 , Publication: Pharmaceutical Executive , Author: Jill Wechsler

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=442277

Q&A with GPhA President and CEO Kathleen Jaeger

Generic Pharmaceutical Association: www.gphaonline.org

Date: 06/01/2007 , Publication: US Pharmacist , Author: Editor

http://www.uspharmacist.com/index.asp?show=article&page=8_2054.htm

The Waxman-Hatch Generic Drug Law

The Waxman-Hatch law is said to have given birth to the modern generic drug industry in the United States

Date: 06/01/2007 , Publication: US Pharmacist , Author: John M. Coster, PhD, RPh

http://www.uspharmacist.com/index.asp?show=article&page=8_2052.htm

Generic Industry Outlook

Dynamic Changes Require Informed Decision Making

Date: 06/01/2007 , Publication: US Pharmacist , Author: Editor

http://www.uspharmacist.com/index.asp?show=article&page=8_2048.htm

Get ready for all NPI contingencies

Less than a month before the implementation deadline for the new National Provider Identifier (NPI) numbers, confusion and concern continue to mount

Date: 05/07/2007 , Publication: Drug Topics , Author: Reid Paul

http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=423914

Final PDUFA Recommendations Transmitted to Congress Will Strengthen Drug Review and Drug Safety

PDUFA provides user fee funds, paid by brand drug and biotechnology companies that are added to appropriated funds to support the review of new human drugs

Date: 03/23/2007 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/NEWS/2007/NEW01592.html

Bush health plan would boost govt. revenue

Congressional advisers estimate proposals would cost taxpayers $526B

Date: 03/01/2007 , Publication: MSNBC , Author: Associated Press

http://www.msnbc.msn.com/id/17397795/

Experts debate Medicare negotiation legislation

Legislation to mandate government negotiation on Medicare Part D drug prices has now passed the U.S. House of Representatives

Date: 02/19/2007 , Publication: Drug Topics , Author: Kathryn Foxhall

http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=404999

Previous Page 1 of 6 Next >

Search returned 59 items.